A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, phase III clinical trial to
investigate the efficacy and safety of evogliptin after oral administration in patients with
type 2 diabetes who have inadequate glycemic control on diet and exercise.